Assessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod.
Correale J, Chiquete E, Milojevic S, Frider N, Bajusz I
Drug Des Devel Ther. 2014; 8:859-67. Epub 2014 Jun 25. PMID: 25028537.Abstract